Published Date:2024-05-03 Original Link:https://www.onenessbio.com/en/news_detail282_4.htm No 1 Date of announcement 2024/05/03 Time of announcement 17:15:55 Subject Announcement the Company’s board of directors meeting date of the First Quarter of 2024 Consolidated Financial Reports To which item it meets paragraph 31 Date of events 2024/05/03 Statement Date of a notice of the board of directors meeting is...Read More
Published Date:2024-05-02 Original Link:https://www.onenessbio.com/en/news_detail281_4.htm No 1 Date of announcement 2024/05/02 Time of announcement 17:53:51 Subject Oneness Biotech Co., Ltd. receives a Japanese patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/05/02 Statement Date of occurrence of the event: 2024/05/02...Read More
Published Date:2024-04-22 Original Link:https://www.onenessbio.com/en/news_detail280_4.htm No 1 Date of announcement 2024/04/22 Time of announcement 18:16:38 Subject Subcutaneous injection formulation of FB825 to treat moderate-to-severe atopic dermatitis was greenlighted by TFDA to proceed with a Ph2 study To which item it meets paragraph 10 Date of events 2024/04/22 Statement Date of occurrence of the event:2024/04/22 New drug...Read More
Published Date:2024-03-29 Original Link:https://www.onenessbio.com/en/news_detail279_4.htm No 1 Date of announcement 2024/03/29 Time of announcement 18:08:07 Subject Submission of a phase II clinical trial protocol to Taiwan FDA for subcutaneous injection formulation of FB825 in patients with moderate-to-severe atopic dermatitis To which item it meets paragraph 10 Date of events 2024/03/29 Statement Date of occurrence of the...Read More
Published Date:2024-03-22 Original Link:https://www.onenessbio.com/en/news_detail278_4.htm No 1 Date of announcement 2024/03/22 Time of announcement 17:16:28 Subject Oneness announces the information about the investor’s conference of 2024 Q1. To which item it meets paragraph 12 Date of events 2024/03/29 Statement Date of institutional investor conference:2024/03/29 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More
Published Date:2024-03-19 Original Link:https://www.onenessbio.com/en/news_detail277_4.htm No 1 Date of announcement 2024/03/19 Time of announcement 18:29:34 Subject Oneness Biotech Co., Ltd. receives a Saudi Arabian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/03/19 Statement Date of occurrence of the event:2024/3/19...Read More
Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail274_4.htm No 8 Date of announcement 2024/02/29 Time of announcement 17:45:14 Subject Announce the change of the internal audit officer. To which item it meets paragraph 8 Date of events 2024/02/29 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer,...Read More
Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail273_4.htm No 7 Date of announcement 2024/02/29 Time of announcement 17:42:49 Subject The board of directors of the Company approved removal of the noncompete clause for managers. To which item it meets paragraph 21 Date of events 2024/02/29 Statement Date of the board of directors resolution: 2024/02/29 Name and title of the...Read More
Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail272_4.htm No 6 Date of announcement 2024/02/29 Time of announcement 17:40:23 Subject Annouce the change of the spokesperson. To which item it meets paragraph 8 Date of events 2024/02/29 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance...Read More
